chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with Hep B vaccine recombinant (Engerix-B0 for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history concurrent conditions, and concurrent medications were not  reported. the subject received injections of Engerix B on 06 April 1995 (Lot ENG 1512B2), 16 May 1995 (lot ENG1742A2), and 08 Jan 1996 (lot ENG1816A2). He also received combination diphtheria and tetanus toxoids and pertussis/Haemophilus influenza type B conjugate vaccine (Tetramune: 16 May 1995, 18 July 1995, and 20 Sept 1995), diphtheria and tetanus and acellular pertussis vaccine (Acel Immune 18 Sept 1996), Haempohilus influenza type b conjugate vaccine (Act HIB, 28 March 1996), oral poliomyelitis virus vaccine (Orimune 16 May 1995, 18 July 1995, and 20 Sept 1995), MMRII 17 June 1996), and varicella virus vaccine (Varivax 11 April 1997). He also received an injection of tuberculin purified protein derivative (TB Mantoux 08 Jan 1996). The subject's attorney alleged that, as a result of the vaccines administered, the subjects suffers from the effects of mercury poisoning. The mercury poisoning in this report is considered medically serious.
Red areas - about 1 inch across - 5 areas on left arm below injection site - sore chills - 2 episodes -1 night of sweating generalized achiness Resolved all within one week
collapses and dies; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves a 27 years old male patient who collapses and dies while receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a serious event collapses and dies (circulatory collapse) (unknown latency) following the administration of Influenza Vaccine.   Action taken : not applicable.  Corrective treatment : No corrective treatment reported for the event.  Event outcome : At time of reporting, the outcome was Fatal for the event collapses and dies is unknown if an autopsy was done. The cause of death was reported as Collapse circulatory.  Seriousness criteria : This event was assessed as medically significant and was leading to death. Final diagnosis was (fatal) collapses and dies.; Sender's Comments: Sanofi company comment dated 03-Feb-2022. This case involves a 27 years old male patient who collapses and dies while receiving vaccine Influenza Vaccine. The causal role of the suspect vaccine cannot be assessed based on the temporal relevance. Further information regarding concurrent condition during vaccination, previous vaccination, tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Further information regarding the latency to onset, family history for unexplained death, previous history/risk factors, therapy details, corrective treatment (interventional therapy), autopsy details would aid in a comprehensive case assessment.; Reported Cause(s) of Death: collapses
Information has been received from a nurse concerning multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On unknown dates, the patients were vaccinated with GARDASIL 9 (dose, strength, frequency, route of administration, anatomical location, lot # and expiration date were not reported), for prophylaxis. Concomitant therapies included properly stored STERILE DILUENT. The administered vaccines were improperly stored at temperature greater than 9°C but less than 25°C for 1 hour and 13 minutes without any previous temperature excursion; this information was registered in a digital data logger. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA002314: US-009507513-1706USA002914: US-009507513-1706USA002916: US-009507513-1706USA002917.
Chest pain and spasms 14hrs after vaccination, went to ER, diagnoses with PVCs, which I never had before the shot. Over the next week my ears, especially the left, began to feel full. Significant tinnitus noticed a week later along with hearing loss. Went to an ENT and hearing test showed hearing loss at high frequencies. Prednisone, and then nortriptyline was prescribed. Little to no improvement six months later. Several weeks after the shot experienced extreme dermatitis, even on hands and was unable to wear my 18k wedding rings. My jeweler dipped them in 24k gold, and without me telling him about the vaccine, he said that something in my body must be reacting to the metal. Citrus fruits and tomatoes also seemed to trigger rashes. Around this time I also began to experience pins and needles/neuropathy like symptoms, and some limb weakness. I also experienced the worst seasonal allergies after the shot and never had them before. Prior to the shot I was seropositive for COVID antibodies. Since the shot I have not felt the same and was previously fit and healthy. The adverse reactions have decreased my quality of life.
10/22 received flumist  10/23-pt had all over body aches t-102, chills, temp returned to normal with tylenol and motrin. 10/27-finally felt well enough to go to work.  shaky with walking, heavy head, hands, feet, tired.  11/4-chest pain radiating up to neck and left arm. nausea diarrhea x5 decreased heart rate and b/p.  admitted to hospital.  2/17/09 Received hospital medical records of 11/4-11/6/2008. FINAL DX: suspect viral syndrome possibly secondary to nasal flu vaccine; rhabdomyolysis possibly secondary to above; left bundle branch block; mild congestive cardiomyopathy w/LV dysfunction; bradycardia; diarrhea. Records reveal patient experienced chest pressure, nausea, lightheadedness, general discomfort.  Cardio & Neuro consult done.  Improved w/IVF & d/c to home w/serial labs.
This spontaneous report was received from a healthcare worker referring to an unknown number of patients that may have been vaccinated with a dose of GARDASIL (dose, route and lot # not reported). The healthcare worker reported that an unknown number of doses of GARDASIL that were exposed to 10 degrees C for 1 hour and 17 minutes then exposed to 8.7 degrees C for 28 minutes may have been administered. No adverse effect reported. This is one of two reports from the same reporter source. Additional information is not expected due to no other information was available at the time of the report.
Received 0.5mL booster dose,Got the whole dose; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Received 0.5mL booster dose,Got the whole dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Immunocompromised.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 ml. On 27-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Received 0.5mL booster dose,Got the whole dose). On 27-Oct-2021, ACCIDENTAL OVERDOSE (Received 0.5mL booster dose,Got the whole dose) had resolved.            Concomitant information was not provided. Treatment information was not provided.
10:15 AM rec?d shot  8:30 PM chills, fever, severe joint pain - took 800 mg Motrin 11:00 PM difficulty breathing - throat constricting, rash on face and left arm.   Took Tylenol Extra Strength  at about 4:00 AM on 4/17 continued to have chills, fever, severe joint pain but difficulty breathing  had stopped by morning on 4/17 and rash went away.  Started icing left arm on and off. Continued to take Tylenol every 8 hours. Had symptoms of joint pain and weakness (no more fever or chills)  through 4/19. Continuing to have left shoulder pain and lymph nodes are swollen as of 4/22.  Please note, I had similar side effects after every shot with the symptoms getting increasingly worse each time. This is the first time I had difficulty breathing and my throat constricting.
Painful induration at injection sites of upper right thigh. Child was treated at the ER with Keflex but it is unclear to me that Keflex was needed. Recovering.
a warm  pink rash  extending out 2 inches from injection site in a "half-moon"  aspect, with a small amount of pain when touched/pressed
10 patients received doses from an expire vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 patients received doses from an expire vial) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 054C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 patients received doses from an expire vial). On 24-Jun-2021, EXPIRED PRODUCT ADMINISTERED (10 patients received doses from an expire vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medication was provided. No treatment  was provided.
INAPPROPRIATE PRODUCT STORAGE (FIVE VIALS STORED AT 35.05 DEGREES FAHRENHEIT FOR 4 HOURS AT THE TIME THEY WERE UNPUNCTURED); INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On SEP-2022, the patient experienced inappropriate product storage (five vials stored at 35.05 degrees fahrenheit for 4 hours at the time they were unpunctured). On SEP-2022, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the inappropriate product storage (five vials stored at 35.05 degrees fahrenheit for 4 hours at the time they were unpunctured) and incorrect product storage was not reported. This report was non-serious.
Per daycare provider fever 103, got light blue around lips, increased motor activity then brief post ictal phase. ambulance called taken to ER where they were intercepted by parents who signed him out AMH and took him to another ER by private car. He was seen and diagnosed with febrile seizure and URI.
A report was received from a distributor on 10/06/2003 concerning a 70 year old male vaccinee who felt uncomfortable on the same day as receiving Fluvirin vaccine on 09/25/2003 and developed Stevens-Johnson syndrome with mouth ulceration requiring hospitalization an unspecified length of time after receiving Fluvirin vaccine.  On the evening of 09/25/2003 the vaccinee felt uncomfortable.  An unspecified length of time after vaccination the vaccinee experienced mouth ulcerationand Stevens-Johnson syndrome was diagnosed.  The vaccine was admitted to an intensive care unit on an unspecified date in order to prevent infection.  The outcome of the events was not reported. There was insufficient information to determine the reporter's causality assessment.  Follow up pending. Update 1, 23 February 2004: A follow up report was received from a distributor which indicated that the vaccinee had ulceration of the urological system making it difficult for him to control his urine. The vaccinee had cataracts before he received Flurivin and his vision is now worse thatn before vaccination. The operation to rectify the cataracts cannot go ahead of the ulcerations.
Systemic: Fainting / Unresponsive-Medium, Systemic: Seizure-Mild, Additional Details: Patient fainted while seated after receiving vaccine. Fell on floor and hit head. Potential seizure may have occurred, patient mouth observed to be slouched and words slurred afterward. 911 called and full assessment performed by EMT.
Prolonged ongoing cough and congestion. This has been a chronic issue now for over 3 months since a couple of months past the vaccination. Treated with 3 rounds of antibiotics. Cough and congestion still persist. Also, the patient is able to transmit the cough to others.
fever of 102; immediate pain at site/pain at injection site; chills; headache; aches; fatigue; This is a spontaneous report from a non-contactable consumer or other non-HCP (patient reported for self). A 65-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0158), via an unspecified route of administration, administered in left arm on 22Apr2021 09:45 at the age of 65-year-old) as DOSE 2, SINGLE (for COVID-19 immunization. Medical history included hypertension. Known allergies includes allergy to Doxycycline (Drug hypersensitivity). Concomitant medications/medication in two weeks included atorvastatin calcium (LIPITOR); amlodipine; acetylsalicylic acid (BABY ASPIRIN); ubidecarenone (COQ10 [UBIDECARENONE]); ezetimibe (ZETIA) administered in two weeks of vaccination. Facility type vaccine mentioned as Other. The patient had earlier received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8733), via an unspecified route of administration, administered in right arm on 30Mar2021 10:00 (at the age of 64-years-old)) as DOSE 1, SINGLE for covid-19 immunization and experienced little to no reaction. The patient did not receive any other vaccine in four weeks. The patient did not had COVID prior vaccination. On 22Apr2021 11:45, the patient experienced immediate pain at site; fever of 102 (also reported as, 10hrs post vacc), aches, chills, headache lasting 36 hours; then fatigue and pain at injection site (also reported as, 4 days post injection). The patient underwent lab tests and procedures which included body temperature: 102 (fever of 102) on 22Apr2021. Patient was not tested for COVID post vaccination. No treatment was given for the reported events. The outcome of all events was recovering.  No follow-up attempts are possible. No further information is expected.
The day after getting my first dose of the covid vaccine I stood up from my couch and walked into my kitchen, I lost vision and fell on the kitchen floor. Two days later I fell down my stairs. I also got a bladder infection three days after the shot.
pt stated she started having body aches with sweating with out  fever.  She also has fatigue and light headiness.  Pt has not contacted her PCP at this time.
Swelling of face, lips, flushing of skin, generalized Urticaria, no shortness of breath, no wheezing.  Given epinephrine, Dexamethasone, Ibuprofen, Benadryl.
Noticed a trail of tiny clots on Right Arm a week later. Started feeling ill about 3 weeks later. Hospitalized for 4 days. I was given blood thinner intravenously Permanently on Eliquis (blood thinner)
24 hours after administration of the moderna bivalent vaccine, the patient reports developing a large bruise on the arm with blister developing about 4 inches in diameter. This presentation was painful and warm to the touch. Patient presented to the pharmacy 11/7 and still had residual bruise noticeable and marked soreness of the arm. The patient advised us that she is also part of an ongoing RSV (respiratory syncytial virus) vaccine trial and she received the RSV vaccine two months prior in the same arm.
SLIGHT HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination.The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced slight headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight headache. This report was non-serious.
Tinnitus; Parestesia rt side; Facial pressure rt side; Facial Numbness rt side; headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus), PARAESTHESIA (Parestesia rt side), FACIAL DISCOMFORT (Facial pressure rt side), HYPOAESTHESIA (Facial Numbness rt side) and HEADACHE (headache) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2020 at 3:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2020 at 3:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TINNITUS (Tinnitus), PARAESTHESIA (Parestesia rt side), FACIAL DISCOMFORT (Facial pressure rt side), HYPOAESTHESIA (Facial Numbness rt side) and HEADACHE (headache). The patient was treated with PREDNISONE for Adverse event, at a dose of 40 mg and ACETAZOLAMIDE (DIAMOX [ACETAZOLAMIDE]) ongoing since an unknown date for Tinnitus, at a dose of 500 mg. At the time of the report, TINNITUS (Tinnitus) was resolving and PARAESTHESIA (Parestesia rt side), FACIAL DISCOMFORT (Facial pressure rt side), HYPOAESTHESIA (Facial Numbness rt side) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Normal. On an unknown date, Computerised tomogram: normal (normal) Normal. On an unknown date, Magnetic resonance imaging: normal (normal) Normal - MRIs (w/ & w/o contrast). On an unknown date, SARS-CoV-2 antibody test: negative (Negative) negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported by reporter. In order of onset (time of symptom): Tinnitus rt side (7plus mo, continuing), Headaches (3 mo), facial pressure rt side (3 mo), facial numbness rt side (1 week), Parestesia rt side (1 mo).   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received on 01-SEP-2021: Contains Significant information - Updated Patient demographics, Lab data, Treatment medications and  new events added.
Client's mother reported the child had a severe rash to bilateral legs with itching 2 weeks after administration of several vaccines.  The mother stated that only the varicella was was new for the client.  Benadryl and hydrocortisone cream did not help rash go away.
4/25-arm very painful at site-cool compress. 4/26 site red blotches and painful-unable to lift arm. Ceftin 500 mg BID x 10 days and compresses- peach size swelling
pt recvd vax;exp a very intense case of urticaria exactly 20 days p/ vax;
This patient received 1 dose of Pfizer COVID 19 vaccine in January, 2021; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (This patient received 1 dose of Pfizer COVID 19 vaccine in January, 2021) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   In January 2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (This patient received 1 dose of Pfizer COVID 19 vaccine in January, 2021). At the time of the report, OFF LABEL USE (This patient received 1 dose of Pfizer COVID 19 vaccine in January, 2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Pt. given HPV and MCV4 on 9/17/12 - site where HPV given pt. had radiating jaw pain and facial tingling. Pt had 2nd HPV alone on 11/19/12 and had the same reaction.  Pt in for PE today and offered 3rd HPV but declined and told Dr. this info.
I RECEIVED THE TDAP VACCINE AT 0800 AND ABOUT 0803 I STARTED TO FEEL VERY LIGHTHEADED, DIZZY, VERY FLUSHED, AND JITTERY.  I WENT TO THE ER AND MY BP WAS 200/110. THEY PUT ME ON O2, HEART MONITOR, AND AFTER ONE HOUR MY BP WAS STILL VERY HIGH.  THEY GAVE ME A CATAPRES TABLET.  ABOUT 30 MINUTES LATER MY BP WAS DOWN TO 157/86. HX HBP. TOOK 10MG VASOTEC AT 0400 BEFORE WORK.
patient came to clinic c/o  right lower leg swelling on 4/6/2021, on 4/13/2021 she underwent a doppler us and was dx with right common femoral vein thrombus.  her platelets are normal
swollen lymph nodes under right arm, right chest wall, right neck, fever, pain in muscle, pain in hands, swelling in right leg, swelling in hands, headache, feet hurt under bottom,